Merck to Pay $950M To Settle Vioxx Lawsuit Over Off-Label Marketing

|

To settle claims by the federal government that it illegally marketed the recalled drug Vioxx, Merck has agreed to pay nearly $1 billion. 

The U.S. Department of Justice (DOJ) announced on Tuesday that it had reached a Vioxx settlement with the pharmaceutical giant and that Merck will plead guilty to violating federal law and promoting Vioxx illegally.

Merck was accused of promoting Vioxx for the treatment of rheumatoid arthritis before it received approval for that use from the FDA in 2002. The drug maker later issued a Vioxx recall in 2004, after the pain medication was found to double the risk of heart attacks and strokes.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

Merck will pay a $321,636,000 criminal fine for illegal off-label marketing of Vioxx, the DOJ reports. The company will also pay a $628,364,000 civil fine over off-label marketing and what the DOJ calls false statements over the drug’s cardiovascular safety. The civil fine will be divided between the U.S. government and participating Medicaid states. 

Merck has already had to pay $4.85 billion to settle Vioxx lawsuits filed on behalf of individuals who suffered an injury after using the medication. The lawsuits accused the company of failing to warn patients about the potential Vioxx side effects, even though evidence suggested Merck was aware of the risks long before the recall was issued.

Federal investigators say that Merck lied about the safety of Vioxx to increase the drug’s sales, which led to Medicaid agencies in the states and the federal government issuing reimbursements under false pretences.   

In addition to money, Merck has agreed to enter into a corporate integrity agreement with the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services. The agreement will give the OIG expanded oversight and review procedures over the company in order to monitor Merck’s activities and prevent future illegal marketing tactics. 

Federal law makes it illegal for drug manufacturers to promote a drug for a use that has not been approved by the FDA. While such “off-label” marketing is illegal for the manufacturer, doctors have the ability to prescribe whatever drug they see fit.


3 Comments


Isaac
Almost died taking alive put a hole in my stomach had to have surgery

vdeboer
i received some compensation for a heart attack from taking vioxx. medicare fled a lein and took a part of the settlement. will i receive any of this back and also will i be elgible for any part of the new funds?

Daniel
Be aware of drugs that potentiate diabetes. Eli Lilly Zyprexa Olanzapine issues linger. The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease. The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays.One in 145 adults died in clinical trials of those taking the antipsychotic drug Zyprexa. This was Lilly’s #1 product $5 billion per year sales,moreover Lilly also make billions more on drugs that treat diabetes. — Daniel Zyprexa victim activist and patient.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A Wisconsin woman has filed a Depo-Provera brain tumor lawsuit, alleging that she continued using the birth control injection for years after her diagnosis due to the manufacturers’ failure to provide adequate warnings about the potential risk of developing a meningioma.
Following the rapid expansion of legalized sports betting across the U.S., a new watchdog report reveals how the gambling industry lobbied against consumer protections to prevent sports betting addictions, while wagers reached $148 billion annually.
A group of 11 lawsuits over complications associated with Bard PowerPort and other implantable port catheters will be prepared for a series of early bellwether trials in the federal MDL.